Total Payments
$2,066
2023 Payments
$222.38
Companies
29
Transactions
131
Medicare Patients
4,647
Medicare Billing
$211,846
Payment Breakdown by Category
Food & Beverage$2,066 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,066 | 131 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $659.48 | 44 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $267.41 | 10 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $251.65 | 18 | $0 (2019) |
| GlaxoSmithKline, LLC. | $91.06 | 7 | $0 (2020) |
| Almatica Pharma LLC | $71.76 | 5 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $65.21 | 5 | $0 (2019) |
| PFIZER INC. | $61.73 | 4 | $0 (2019) |
| Genentech USA, Inc. | $51.92 | 4 | $0 (2022) |
| Allergan, Inc. | $44.90 | 2 | $0 (2020) |
| Merck Sharp & Dohme LLC | $42.21 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $222.38 | 5 | AstraZeneca Pharmaceuticals LP ($162.92) |
| 2022 | $190.25 | 14 | Almatica Pharma LLC ($71.76) |
| 2021 | $83.82 | 5 | Novo Nordisk Inc ($22.53) |
| 2020 | $308.57 | 22 | Novo Nordisk Inc ($133.79) |
| 2019 | $272.45 | 25 | Novo Nordisk Inc ($114.98) |
| 2018 | $322.08 | 24 | Novo Nordisk Inc ($67.26) |
| 2017 | $666.83 | 36 | Novo Nordisk Inc ($274.66) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/21/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Oncology | ||||||
| 06/01/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Diabetes | ||||||
| 04/21/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.87 | General |
| 04/20/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $115.88 | General |
| Category: Respiratory | ||||||
| 03/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), BREZTRI | Food and Beverage | In-kind items and services | $47.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2022 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/05/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/05/2022 | Almatica Pharma LLC | GRALISE (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: POSTHERPETIC NEURALGIA | ||||||
| 07/01/2022 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: ANTI-ANXIETY | ||||||
| 06/03/2022 | Almatica Pharma LLC | GRALISE (Drug), CITALOPRAM, SERTRALINE HCL | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: POSTHERPETIC NEURALGIA | ||||||
| 05/23/2022 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: ANTI-ANXIETY | ||||||
| 05/16/2022 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Neurology | ||||||
| 04/13/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), VAXNEUVANCE | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: VACCINE | ||||||
| 04/07/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2022 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Neurology | ||||||
| 03/09/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Gastroenterology | ||||||
| 02/22/2022 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Virology & Specialty Care | ||||||
| 02/20/2022 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Neurology | ||||||
| 01/26/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Diabetes | ||||||
| 11/23/2021 | Nabriva Therapeutics, plc | Xenleta (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Antibiotic | ||||||
| 10/05/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Virology & Specialty Care | ||||||
| 09/22/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/25/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Diabetes | ||||||
| 04/21/2021 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,258 | 1,919 | $92,837 | $58,822 |
| 2022 | 18 | 887 | 1,466 | $119,302 | $46,918 |
| 2021 | 26 | 969 | 1,349 | $113,762 | $46,938 |
| 2020 | 31 | 1,533 | 2,271 | $82,651 | $59,168 |
Total Patients
4,647
Total Services
7,005
Medicare Billing
$211,846
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 259 | 404 | $42,709 | $27,279 | 63.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 125 | $19,196 | $11,804 | 61.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 128 | 141 | $4,738 | $4,453 | 94.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $5,944 | $2,920 | 49.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 67 | 87 | $3,975 | $2,421 | 60.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $4,336 | $2,064 | 47.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 66 | 125 | $2,338 | $1,431 | 61.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 26 | $1,627 | $1,064 | 65.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 22 | 23 | $1,086 | $796.26 | 73.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 39 | 40 | $704.14 | $648.00 | 92.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 77 | 86 | $972.60 | $646.85 | 66.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 18 | 38 | $743.40 | $616.36 | 82.9% |
| 74022 | X-ray series of abdomen with single x-ray of chest | Office | 2023 | 15 | 16 | $920.96 | $594.56 | 64.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 17 | 18 | $945.36 | $577.58 | 61.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 40 | 41 | $789.75 | $456.17 | 57.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 116 | 140 | $537.65 | $443.94 | 82.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 94 | 100 | $496.25 | $220.00 | 44.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 16 | 23 | $240.12 | $171.78 | 71.5% |
| 82948 | Blood glucose (sugar) measurement using reagent strip | Office | 2023 | 22 | 25 | $165.76 | $118.56 | 71.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 36 | 154 | $310.38 | $53.99 | 17.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 21 | $32.97 | $21.87 | 66.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 28 | 225 | $29.25 | $20.41 | 69.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 206 | 300 | $52,593 | $20,703 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 88 | $23,393 | $8,919 | 38.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 90 | 98 | $13,547 | $4,129 | 30.5% |
About Dr. Steven Risman, MD
Dr. Steven Risman, MD is a Emergency Medicine healthcare provider based in Belleville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1427108554.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Risman, MD has received a total of $2,066 in payments from pharmaceutical and medical device companies, with $222.38 received in 2023. These payments were reported across 131 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,066).
As a Medicare-enrolled provider, Risman has provided services to 4,647 Medicare beneficiaries, totaling 7,005 services with total Medicare billing of $211,846. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Belleville, NJ
- Active Since 01/11/2007
- Last Updated 07/08/2007
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1427108554
Products in Payments
- Victoza (Drug) $268.22
- Tresiba (Drug) $149.37
- FARXIGA (Drug) $138.33
- Saxenda (Drug) $125.84
- BREZTRI (Drug) $115.88
- AIRDUO (Drug) $103.98
- Ozempic (Drug) $87.49
- PROAIR (Drug) $83.94
- NUEDEXTA (Drug) $65.21
- Trintellix (Drug) $63.30
- VRAYLAR (Drug) $59.63
- Xofluza (Drug) $51.92
- XIFAXAN (Drug) $47.89
- AJOVY (Drug) $45.95
- LOREEV XR (Drug) $43.07
- APLENZIN (Drug) $40.44
- TOUJEO (Drug) $29.34
- GRALISE (Drug) $28.69
- Odactra (Drug) $27.90
- CHANTIX (Drug) $27.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Belleville
James Thomas, Do, DO
Emergency Medicine — Payments: $26,984
Emergency Medicine $26,984
John Fontanetta, Md, MD
Emergency Medicine — Payments: $8,182
Emergency Medicine $8,182
Robert Giles, Md, MD
Emergency Medicine — Payments: $5,245
Emergency Medicine $5,245
Joanne Ahn, M.d, M.D
Emergency Medicine — Payments: $2,093
Emergency Medicine $2,093
Dr. Patrick Davis, Md, MD
Emergency Medicine — Payments: $1,878
Emergency Medicine $1,878
Nilesh Kansagra, Md, MD
Emergency Medicine — Payments: $1,236
Emergency Medicine $1,236